Back to search

Article

SARS-CoV-2 Beta variant infection elicits potent lineage-specific and cross-reactive antibodies

2021-09-30

Abstract excerpt

SARS-CoV-2 Beta variant of concern (VOC) resists neutralization by major classes of antibodies from non-VOC COVID-19 patients and vaccinated individuals. Here, serum of Beta variant infected patients revealed reduced cross-neutralization of non-VOC virus. From these patients, we isolated Beta-specific and cross-reactive receptor-binding domain (RBD) antibodies. The Beta-specificity results from recruitment of nove...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
9bb42719-d5ea-5e76-ae29-7c7fb535b50d
DOI
10.1101/2021.09.30.462420
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
SARS-CoV-2 Beta variant infection elicits potent lineage-specific and cross-reactive antibodiesDOI 10.1101/2021.09.30.462420
Select a neighboring publication to make it the new centre.